A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

Clinical trial NCT06254495 · TERMINATED

Trial details

NCT number: NCT06254495
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Disease Lymphoma, T-Cell, Peripheral Lymphoma, Large B-Cell, Diffuse Lymphoma, Large-Cell, Anaplastic

Start date: 2024-05-28
Primary completion: 2026-04-13
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.